References for metastatic malignant melanoma

Chemo Secrets From a Breast Cancer Survivor

Breast Cancer Survivors

Get Instant Access

1. Balch CM, Reintgen DS, Kirkwood JM et al. Cutaneous melanoma. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 5th ed. Philadelphia: Lippincot-Raven 1997:1947-94.

2. Unger JM, Flaherty LE, Liu PY et al. Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group Trials. Cancer 2001;91: 1148-55.

3. Crosby T, Fish R, Coles B, Mason MD. Systemic treatments for metastatic cutaneous melanoma. In: Cochrane Collaboration. Cochrane Library. Issue 2. Oxford: Update Software, 2002.

4. Balch CM, Houghton AN, Peters LJ. Cutaneous melanoma. In: Devita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia: JB Lippincott 1993:1612-61.

5. Cascinelli N, Clemente C, Belli F. Cutaneous melanoma. In: Peckham M, Pinedo HM, Veronesi U, eds. Oxford Textbook of Oncology. Oxford: Oxford University Press, 1995:902-28.

6. Pritchard KI, Quirt IC, Cowman DH et al. DTIC therapy in metastatic malignant melanoma: A simplified dose schedule. Cancer Treat Rep 1980;64:1123-6.

7. Taylor A, Gore M. Malignant melanoma. In: Price P, Sikora K, eds. Treatment of Cancer, 3rd ed. London: Chapman and Hall Medical, 1995;37:763-7.

8. Middleton MR, Grob JJ, Aaronson N et al. Randomised phase III study of temozolamide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000; 18:158-66.

9. Chapman PB, Einhorn LH, Meyers ML et al. Phase III multicenter randomised trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999;17:2745-51.

10. Falkson CI, Falkson G, Falkson HC. Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma. J Clin Oncol 1991;9:1403-8.

11. Del prete SA, Maurer LF, O'Donnell J et al. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat Rep 1984;68:1403-5.

12. Cocconi G, Bella M, Calabresi F et al. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl Med J 1992;327:516-23.

13. Falkson CI, Ibrahim J, Kirkwood JM, Coates AS, Atkins MB, Blum RH. Phase III trial of dacarbazine versus dacarbazine with interferon-alpha2b versus dacarbazine with tamoxifen versus dacarbazine with interferon-alpha 2b and tamoxifen in patients with metastatic malignant melanoma: An Eastern Cooperative Oncology Group Study. J Clin Oncol 1998;16:1743-51.

14. Rosenberg SA, Yang JC, Topalian SL et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin-2. JAMA 1994;271:907-13.

15. Legha SS. The role of interferon alfa in the treatment of metastatic melanoma. Semin Oncol 1997;24:S24-31.

16. Legha SS, Gianin MA, Plager C et al. Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melnoma. Cancer 1996: 77:89-96.

17. Atzpodien J, Kirchner H, Franzke A et al. Results of a randomised clinical trial comparing SC interleukin-2, SC alpha-2a-interferon, and IV bolus 5-fluorouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients. Proc Am Assoc Clin Oncol 1997; 16:326.

18. Huncharek M, Caubet JF, McGarry R. Single agent DTIC versus combination chemotherapy with or without imunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomised trials. Melanoma Res 2001;11:75-81.

19. Kirkwood JM, Strawderman MH, Erstoff MS et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684. J Clin Oncol 1996;14:7-17.

20. Kleeberg UR, Brocker EB, Lejeune F. Adjuvant trial in melanoma patients comparing rIFN-alfa to rIFN-gamma to Iscador to a control group after curative resection high risk primary or regional lymph node metastasis (EORTC 18871). Eur J Cancer 1999;35(Suppl. 4):S82.

Was this article helpful?

0 0
How To Prevent Skin Cancer

How To Prevent Skin Cancer

Complete Guide to Preventing Skin Cancer. We all know enough to fear the name, just as we do the words tumor and malignant. But apart from that, most of us know very little at all about cancer, especially skin cancer in itself. If I were to ask you to tell me about skin cancer right now, what would you say? Apart from the fact that its a cancer on the skin, that is.

Get My Free Ebook

Post a comment